COVID-19 Dominates Top 10 UArizona Health Sciences News Stories of 2020 Dec. 16, 2020 Antibody tests, groundbreaking research and community outreach are a few of the ways the University of Arizona Health Sciences met the test of a pandemic. Read more Image
Top 10 UArizona Health Sciences News Stories of 2020 Dec. 16, 2020 Antibody tests, groundbreaking research and community outreach are a few of the ways the University of Arizona Health Sciences met the test of a pandemic. Read more Image
Combating Misinformation with ‘COVID Mythbusters’ Dec. 16, 2020 A UArizona Health Sciences public health student and a microbiology student in Canada won a science competition with an Instagram account to refute bad science. Read more Image
Controlling T-Cells to Attack Cells Linked to Type-1 Diabetes Edit Dec. 16, 2020 An encouraging new study at the University of Arizona could lead to new immunotherapy treatments for Type-1 diabetes and could be extended to other autoimmune diseases. The study involves genetically engineered T-cells that can seek out and destroy pathogens in the pancreas. The research was led by Michael Kuhns, an associate professor of immunobiology in the UArizona College of Medicine - Tucson. KAET-TV (PBS) "Arizona Horizon," Phoenix
Holiday Volunteerism Stymied by Pandemic Dec. 16, 2020 The coronavirus has upended almost all aspects of life this year, and that includes the holiday giving and volunteering that credit unions traditionally do. Kelly Reynolds, a professor and environmental microbiologist at the University of Arizona Mel and Enid Zuckerman College of Public Health, is interviewed. American Banker
Clinical Trial Volunteer Discusses Moderna's COVID-19 Vaccine Dec. 16, 2020 Dr. Sam Keim, a professor of emergency medicine at the University of Arizona College of Medicine - Tucson, is interviewed about his experiences as a clinical trial participant in Moderna's COVID-19 vaccine KNAU-FM (NPR) Flagstaff
Best of Last Year: The Top MedicalXpress Articles of 2020 Dec. 16, 2020 A team at the University of Arizona Health Sciences found that SARS-CoV-2 antibodies provide lasting immunity. This finding suggested that those who had survived an infection and those who received a vaccine for COVID-19 would be immune from reinfection for several months. Medical Xpress
COVID-19 in Patients with Hematologic Malignancies Dec. 16, 2020 Sandra Kurtin, PhD, ANP-C, AOCN, of the University of Arizona Cancer Center, discusses the challenges for advanced practitioners treating patients with hematologic malignancies who are at high risk for COVID-19 infection. Journal of Advanced Practitioner in Oncology
When Can We Start Making Plans? Dec. 16, 2020 Dr. Anthony S. Fauci and several epidemiologists and health and science writers for The New York Times discuss their predictions about the months ahead. "I won't take traveling to my extended family for granted," said Alicia Allen, PhD, MPH, an assistant professor of clinical translational sciences at the University of Arizona College of Medicine – Tucson. The New York Times